EOVIST 181.43 mg/mL
Gadoxetate Disodium · INJECTION, SOLUTION · Bayer HealthCare Pharmaceuticals Inc.
EOVIST is a injection, solution containing gadoxetate disodium at 181.43 mg/mL, taken intravenous. Manufactured by Bayer HealthCare Pharmaceuticals Inc..
Key Facts
- Brand Name
- EOVIST
- Generic Name
- Gadoxetate Disodium
- NDC Code (Product)
50419-320- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- Strength
- 181.43 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA022090
- Marketing Start
- 07/03/2008
Recall History
No Recall HistoryFrequently Asked Questions
What is EOVIST used for?
EOVIST contains Gadoxetate Disodium. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is EOVIST a controlled substance?
EOVIST is not classified as a controlled substance by the DEA.
What is the generic name for EOVIST?
The generic name for EOVIST is Gadoxetate Disodium. There are no other listed brand versions of Gadoxetate Disodium.
What is the NDC code for EOVIST 181.43 mg/mL?
The NDC (National Drug Code) for EOVIST 181.43 mg/mL is 50419-320, listed by Bayer HealthCare Pharmaceuticals Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)